| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $121,725,374 ) (Continued on the next page) |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA285726 | CD200R blockade for cancer immunotherapy | 000 | 2 | NIH | 6/16/2025 | $673,569 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL168045 | Therapeutic Strategies to Mitigate Toxicities of Anthracycline-Based Therapeutics | 000 | 2 | NIH | 12/6/2024 | $671,704 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R03CA280007 | A sensitivity analysis framework for generalizing randomized clinical trial results in the presence of unmeasured treatment effect modifiers | 000 | 2 | NIH | 11/26/2024 | $80,739 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R35GM151095 | Gene positioning and dynamic chromatin organization of the human genome | 000 | 3 | NIH | 5/2/2025 | $382,636 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R21AI180862 | Redox Regulation of Sarcoidosis Granulomas and Fibrosis | 000 | 2 | NIH | 4/28/2025 | $236,250 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA249198 | Targeting cholesterol metabolism and replication stress response in cancer therapy | 001 | 5 | NIH | 6/16/2025 | $35,685 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA249198 | Targeting cholesterol metabolism and replication stress response in cancer therapy | 000 | 5 | NIH | 1/3/2025 | $321,165 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01LM014385 | Generative AI for retrosynthesis libraries | 001 | 2 | NIH | 6/23/2025 | $33,000 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01LM014385 | Generative AI for retrosynthesis libraries | 000 | 2 | NIH | 12/3/2024 | $297,004 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01AI188576 | SCH: Improving Early Prediction and Decision-Making for Sepsis with Human-AI Collaboration | 000 | 2 | NIH | 5/16/2025 | $144,506 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01AI188576 | SCH: Improving Early Prediction and Decision-Making for Sepsis with Human-AI Collaboration | 000 | 2 | NIH | 5/16/2025 | $150,000 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R03CA286694 | Mechanisms of Resistance and Therapeutic Targets in T-LGL Leukemia | 000 | 2 | NIH | 12/3/2024 | $78,750 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01MH133925 | Inflammatory Challenge in Human Aggression | 000 | 1 | NIH | 2/14/2025 | $65,363 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01MH133925 | Inflammatory Challenge in Human Aggression | 001 | 2 | NIH | 3/27/2025 | $38,490 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01MH133925 | Inflammatory Challenge in Human Aggression | 001 | 2 | NIH | 3/27/2025 | $638,721 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01GM149080 | Integrating Accelerated Droplet Chemistry with LC-MS for High Throughput Quantitative Analysis | 000 | 3 | NIH | 12/19/2024 | $275,697 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01LM013879 | Penalized mixture cure models for identifying genomic features associated with outcome in acute myeloid leukemia | 001 | 4 | NIH | 6/6/2025 | $25,821 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01LM013879 | Penalized mixture cure models for identifying genomic features associated with outcome in acute myeloid leukemia | 000 | 4 | NIH | 12/13/2024 | $232,382 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R35GM152205 | Essential functions of OGT in host defense mechanism | 001 | 2 | NIH | 6/17/2025 | $387,489 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R34MH126008 | Optimizing residential treatment gains for adolescents through tailored behavioral parent training | 000 | 3 | NIH | 12/6/2024 | $234,281 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R37CA248371 | Energy Balance, mTOR pathway signaling, and breast cancer prognosis | 001 | 6 | NIH | 6/2/2025 | $71,619 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R37CA248371 | Energy Balance, mTOR pathway signaling, and breast cancer prognosis | 000 | 6 | NIH | 1/9/2025 | $644,581 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA287261 | Fecal microbial transplantation for chemotherapy behavioral side effects | 001 | 2 | NIH | 6/2/2025 | $60,169 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA287261 | Fecal microbial transplantation for chemotherapy behavioral side effects | 000 | 2 | NIH | 1/16/2025 | $541,528 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA248741 | Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer | 001 | 5 | NIH | 5/29/2025 | $74,183 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA248741 | Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer | 000 | 5 | NIH | 2/17/2025 | $667,657 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F31AG089875 | Internet-delivered mindfulness training to reduce cognitive variability in adults with subjective cognitive decline | 000 | 1 | NIH | 6/16/2025 | $37,923 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HL168892 | Vascular mechanisms of sepsis-induced cognitive dysfunction | 000 | 3 | NIH | 2/19/2025 | $626,465 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R03AI183164 | In vitro Pharmacokinetic/pharmacodynamic models for dose de-escalation of antibiotics | 000 | 2 | NIH | 3/11/2025 | $78,750 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | UM1CA239749 | The Cooperative Human Tissue Network Midwestern Division (CHTN MWD) | 003 | 7 | NIH | 5/23/2025 | $81,242 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | UM1CA239749 | The Cooperative Human Tissue Network Midwestern Division (CHTN MWD) | 002 | 7 | NIH | 4/4/2025 | $730,970 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01DK129435 | A Family-Dyad-focused Diabetes Self-Management Intervention for African American Adults with Type 2 Diabetes | 000 | 3 | NIH | 2/17/2025 | $283,500 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA270608 | Electronic cigarette derived free radicals, oxidative stress and inflammation in lung cancer development | 001 | 4 | NIH | 5/23/2025 | $56,545 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA270608 | Electronic cigarette derived free radicals, oxidative stress and inflammation in lung cancer development | 000 | 4 | NIH | 2/14/2025 | $508,919 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA280203 | Role of FACT in ZFTA-RelA fusion driven ependymoma | 001 | 3 | NIH | 5/22/2025 | $69,196 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA280203 | Role of FACT in ZFTA-RelA fusion driven ependymoma | 000 | 3 | NIH | 3/10/2025 | $622,769 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R37CA299879 | Damage-associated molecular patterns in chemotherapy toxicity | 000 | 1 | NIH | 2/25/2025 | $601,091 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R35GM157207 | Lysosomal membrane dynamics during stress | 000 | 1 | NIH | 1/31/2025 | $393,750 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA288444 | Modulation of ferroptotic cell death by mitochondrial calcium signaling | 001 | 2 | NIH | 5/22/2025 | $56,638 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA288444 | Modulation of ferroptotic cell death by mitochondrial calcium signaling | 000 | 2 | NIH | 3/3/2025 | $509,741 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | UG1CA233331 | OSU as a Network Lead Academic Participating Site for the NCI NCTN | 000 | 6 | NIH | 3/13/2025 | $659,950 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R03DE034484 | Nutritional Niches within Supragingival Biofilms | 000 | 1 | NIH | 3/10/2025 | $163,411 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F31ES036102 | The role of endogenous docosahexaenoic acid in resolving ozone induced lung inflammation | 001 | 2 | NIH | 6/12/2025 | -$23,789 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | F31ES036102 | The role of endogenous docosahexaenoic acid in resolving ozone induced lung inflammation | 000 | 2 | NIH | 2/14/2025 | $44,074 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01HS029001 | Pain, Multimorbidity, Opioid-Drug Interactions and Risk for Opioid Use Disorder or Overdose in Older Adults | 000 | 3 | AHRQ | 2/7/2025 | $194,958 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA266402 | Improving Treatment Selection in Advanced Ovarian Cancer | 001 | 4 | NIH | 5/23/2025 | $55,735 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA266402 | Improving Treatment Selection in Advanced Ovarian Cancer | 000 | 4 | NIH | 2/18/2025 | $501,610 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA261068 | Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity | 006 | 6 | NIH | 5/22/2025 | $50,804 |
| | 2025 | 2025 | OHIO STATE UNIVERSITY, THE | 1960 KENNY RD | COLUMBUS | OH | 43210-1016 | FRANKLIN | USA | R01CA261068 | Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity | 005 | 6 | NIH | 2/28/2025 | $408,041 |
|
